InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,185.55
(
0.09%
)
US TECH 100
17,608.40
(
-0.01%
)
Dow Jones
38,876.04
(
0.06%
)
Brent Oil
83.11
(
-0.44%
)
Bitcoin
63,233.35
(
0.10%
)
Post# of 49606
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

westeffer

Send PM Follow Ignore
Followers 572
Posts 9510
Boards Moderated 1
Alias Born 09/03/2004

westeffer

Re: None

Friday, 07/10/2015 10:39:24 AM

Friday, July 10, 2015 10:39:24 AM

Post# of 49606
For those of you with some extra change, you might want to take a look at RXII for their dermatological/Ocular scarring patent portfolio that has some pretty broad applications for surgical scarring as well. A couple of analysts see a short term target of $3+ and currently trading at 50 cents. There is very little new treatment methods available for scarring in healthcare and this could be a very significant breakthrough. JMHO
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up